These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 25252319

  • 1. Prenatal exposure to selective serotonin reuptake inhibitors and autistic symptoms in young children: another red herring?
    Petersen I, Evans S, Nazareth I.
    Br J Psychiatry; 2014 Aug; 205(2):105-6. PubMed ID: 25252319
    [Abstract] [Full Text] [Related]

  • 2. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children.
    El Marroun H, White TJ, van der Knaap NJ, Homberg JR, Fernández G, Schoemaker NK, Jaddoe VW, Hofman A, Verhulst FC, Hudziak JJ, Stricker BH, Tiemeier H.
    Br J Psychiatry; 2014 Aug; 205(2):95-102. PubMed ID: 25252317
    [Abstract] [Full Text] [Related]

  • 3. Depression and SSRI use in pregnancy associated with traits of autism in children.
    Torjesen I.
    BMJ; 2014 Jul 31; 349():g4835. PubMed ID: 25084785
    [No Abstract] [Full Text] [Related]

  • 4. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
    Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.
    BJOG; 2016 Nov 31; 123(12):1908-1917. PubMed ID: 26374234
    [Abstract] [Full Text] [Related]

  • 5. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 6. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.
    Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.
    Autism Res; 2013 Jun 01; 6(3):149-68. PubMed ID: 23495208
    [Abstract] [Full Text] [Related]

  • 7. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I.
    Am J Obstet Gynecol; 2019 Jan 01; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [Abstract] [Full Text] [Related]

  • 8. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
    Engelstad HJ, Roghair RD, Calarge CA, Colaizy TT, Stuart S, Haskell SE.
    Neonatology; 2014 Jan 01; 105(2):149-54. PubMed ID: 24356332
    [Abstract] [Full Text] [Related]

  • 9. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
    Andalib S, Emamhadi MR, Yousefzadeh-Chabok S, Shakouri SK, Høilund-Carlsen PF, Vafaee MS, Michel TM.
    Eur Psychiatry; 2017 Sep 01; 45():161-166. PubMed ID: 28917161
    [Abstract] [Full Text] [Related]

  • 10. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 01; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 11. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC, Meltzer-Brody S, Woolson S, Hamer RM, Smith JK, Lury K, Gilmore JH.
    Neuropsychopharmacology; 2014 Oct 01; 39(11):2611-21. PubMed ID: 24837031
    [Abstract] [Full Text] [Related]

  • 12. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D, Tiemeier H, Stricker BH, Muetzel RL, Hillegers M, El Marroun H.
    JAMA Psychiatry; 2023 Dec 01; 80(12):1208-1217. PubMed ID: 37647036
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun 01; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 14. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL, Kim DR, Epperson CN.
    Psychopharmacology (Berl); 2013 Jun 01; 227(4):567-82. PubMed ID: 23681158
    [Abstract] [Full Text] [Related]

  • 15. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
    Singal D, Chateau D, Struck S, Lee JB, Dahl M, Derksen S, Katz LY, Ruth C, Hanlon-Dearman A, Brownell M.
    Pediatrics; 2020 May 01; 145(5):. PubMed ID: 32341177
    [Abstract] [Full Text] [Related]

  • 16. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.
    Arch Gen Psychiatry; 2012 Jul 01; 69(7):706-14. PubMed ID: 22393202
    [Abstract] [Full Text] [Related]

  • 17. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
    Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Weissman M, Wickramaratne P, Artama M, Gingrich JA, Sourander A.
    J Am Acad Child Adolesc Psychiatry; 2016 May 01; 55(5):359-66. PubMed ID: 27126849
    [Abstract] [Full Text] [Related]

  • 18. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L, Slack-Smith L, Stanley FJ, Bower C.
    CNS Drugs; 2012 Jul 01; 26(7):e1-14. PubMed ID: 22712699
    [Abstract] [Full Text] [Related]

  • 19. Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
    El Marroun H, White TJ, Fernandez G, Jaddoe VW, Verhulst FC, Stricker BH, Tiemeier H.
    J Psychopharmacol; 2017 Mar 01; 31(3):346-355. PubMed ID: 27624153
    [Abstract] [Full Text] [Related]

  • 20. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.